On the menu today: Moderna announces their coronavirus vaccine works and will be easier to store and transport than Pfizer’s; the Georgia recount is almost done; and a sneak preview of Hunting Four Horsemen about how regularly human beings come in contact with new viruses.

What’s Better Than One Effective COVID-19 Vaccine? Two Effective Vaccines!

Arguably even better news than hearing that Pfizer’s coronavirus vaccine is 90 percent effective: The pharmaceutical company Moderna announced this morning that the company’s “experimental vaccine was 94.5 percent effective in preventing COVID-19 based on interim data from a late-stage clinical trial” and — this has big consequences for shipping and distribution — it can be stored in regular refrigerator temperatures.

Stéphane Bancel, CEO of Moderna, said in a released statement, “This is a pivotal moment in the development of our COVID-19 vaccine candidate. Since early January, we have chased this virus with the intent to protect as many people ...

Morning-Jolt.png
WITH JIM GERAGHTY November 16 2020
Morning-Jolt-center.png
WITH JIM GERAGHTY November 16 2020
hero

Great News on the Vaccine Front

On the menu today: Moderna announces their coronavirus vaccine works and will be easier to store and transport than Pfizer’s; the Georgia recount is almost done; and a sneak preview of Hunting Four Horsemen about how regularly human beings come in contact with new viruses.

What’s Better Than One Effective COVID-19 Vaccine? Two Effective Vaccines!

Arguably even better news than hearing that Pfizer’s coronavirus vaccine is 90 percent effective: The pharmaceutical company Moderna announced this morning that the company’s “experimental vaccine was 94.5 percent effective in preventing COVID-19 based on interim data from a late-stage clinical trial” and — this has big consequences for shipping and distribution — it can be stored in regular refrigerator temperatures.

Stéphane Bancel, CEO of Moderna, said in a released statement, “This is a pivotal moment in the development of our COVID-19 vaccine candidate. Since early January, we have chased this virus with the intent to protect as many people ...   READ MORE

spacer

ADVERTISEMENT

BRC_570_002.jpg


Trending on National Review

1. The Online Learning Crisis

2. How Colorado Voters Cut Taxes During a Statewide Blue Wave

3. Wolves and Ephemerality

Top Stories

Alexander William Salter

Confirm Judy Shelton to the Fed Board of Governors

Shelton’s contrarian views would ensure that the Board confronted hard questions head on. Rather than impede ...

Jon Hartley

The Case against Judy Shelton at the Federal Reserve

As the Senate confirmation of Judy Shelton, one of President Trump’s nominees for the Federal Reserve Board, ...

NEWS

Cuomo Threatens to Sue Trump Admin. to Ensure Vaccine Is Distributed to ‘Black and Brown...

The governor claimed the inequities in the plan are made worse by a lack of federal aid to aid states in ...

Jimmy Quinn

Pompeo Kicks Off Post-Election Foreign Trip, in Low-Key Style

The trip appears intended to highlight the Trump administration’s foreign policy ...

The Editors

Biden’s Foolish Immigration Priorities

We were told constantly during the campaign that Joe Biden was a moderate. It was never true and is blatantly ...

NEWS

Moderna Says Coronavirus Vaccine Is Nearly 95 Percent Effective, Trial Data Shows

The drug maker is the second to announce an extremely high success rate for its experimental vaccine.

PODCASTS

PHOTOS

VIDEO

NRPLUS ARTICLES

Ready for Election Season?

National Review subscribers get the most out of National Review. Don’t miss out.

SEE MY OPTIONS

ADVERTISEMENT

 
 
 
Learn more about RevenueStripe...
national review

Follow Us & Share

19 West 44th Street, Suite 1701, New York, NY, 10036, USA
Your Preferences | Unsubscribe | Privacy
View this e-mail in your browser.